Latest On Avanos Medical, Inc (AVNS):
| Date/Time | Type | Description | Signal | Details |
|---|---|---|---|---|
| 2023-05-03 21:24 EST | News | Avanos Medical, Inc. (AVNS) Q1 2023 Earnings Call Transcript | N/A |  |
| 2023-05-03 08:06 EST | News | Avanos Medical Non-GAAP EPS of $0.27 misses by $0.01, revenue of $191.7M misses by $3.5M | N/A | |
| 2023-05-02 20:08 EST | News | Avanos Medical Q1 2023 Earnings Preview | N/A | |
| 2023-04-21 06:32 EST | News | Avanos Medical: Cost Restructuring Could Unlock Substantial Value | N/A | |
| 2023-02-22 10:27 EST | News | Avanos Medical reports Q4 earnings; initiates FY23 outlook | N/A | |
| 2023-02-21 21:57 EST | News | Avanos Medical, Inc. (AVNS) Q4 2022 Earnings Call Transcript | N/A | |
| 2023-02-21 08:13 EST | News | Avanos Medical reports mixed Q4 earnings; initiates FY23 outlook | N/A | |
| 2023-02-20 19:28 EST | News | Avanos Medical Q4 2022 Earnings Preview | N/A | |
| 2022-12-06 15:58 EST | News | Avanos: TriVisc Offering Appealing, Strong Growth Across Rest Of Product Portfolio, Revise To Buy | N/A | |
| 2022-11-05 08:58 EST | News | Avanos Medical, Inc. (AVNS) Q3 2022 - Earnings Call Transcript | N/A | |
| 2022-11-02 14:00 EST | News | Avanos Medical reports Q3 mixed earnings; reaffirms FY22 guidance | N/A | |
| 2022-09-12 14:21 EST | News | Avanos: Recent Entry To Hyaluronic Acid Market Sparks Interesting Debate | N/A | |
| 2022-08-13 08:24 EST | News | Avanos Medical, Inc. 2022 Q2 - Results - Earnings Call Presentation | N/A | |
| 2022-08-13 08:24 EST | News | Avanos Medical, Inc. (AVNS) CEO Joe Woody on Q2 2022 Results - Earnings Call Transcript | N/A | |
| 2022-08-09 19:18 EST | News | Avanos Medical reports Q2 mixed earnings; narrows FY22 guidance | N/A | |
| 2022-08-08 20:40 EST | News | Avanos Medical Q2 2022 Earnings Preview | N/A | |
| 2022-05-08 11:45 EST | News | Avanos Medical, Inc. (AVNS) CEO Joe Woody on Q1 2022 Results - Earnings Call Transcript | N/A | |
| 2022-05-05 22:42 EST | News | Avanos Medical, Inc. 2022 Q1 - Results - Earnings Call Presentation | N/A | |
| 2022-05-04 23:53 EST | News | Avanos Medical Non-GAAP EPS of $0.26 in-line, revenue of $197.4M misses by $0.4M | N/A | |
| 2022-05-04 03:44 EST | News | Avanos Medical Q1 2022 Earnings Preview | N/A | |
| 2022-02-24 09:11 EST | News | Avanos Medical's (AVNS) CEO Joe Woody on Q4 2021 Results - Earnings Call Transcript | N/A | |
| 2022-02-23 13:14 EST | News | Avanos Medical Non-GAAP EPS of $0.46 beats by $0.06, revenue of $193.4M beats by $2.08M | N/A | |
| 2022-02-22 19:02 EST | News | Avanos Medical Q4 2021 Earnings Preview | N/A | |
| 2022-01-24 17:27 EST | News | Avanos Medical (AVNS) Presents At 40th Annual J.P. Morgan Virtual Healthcare Conference | N/A | |
| 2021-12-16 03:03 EST | News | Avanos Medical announces $30M share repurchase program | N/A | |
| 2021-12-14 10:38 EST | News | Avanos Medical agrees to buy OrthogenRx for $160M | N/A | |
| 2021-11-03 08:35 EST | News | Avanos Medical, Inc. (AVNS) CEO Joe Woody on Q3 2021 Results - Earnings Call Transcript | N/A | |
| 2021-11-02 12:34 EST | News | Avanos Medical EPS misses by $0.04, misses on revenue | N/A | |
| 2021-11-01 15:47 EST | News | Avanos Medical 3Q 2021 Earnings Preview | N/A | |
| 2021-08-04 03:22 EST | News | Avanos Medical, Inc. 2021 Q2 - Results - Earnings Call Presentation | N/A | |
| 2021-08-04 03:20 EST | News | Avanos Medical, Inc. (AVNS) CEO Joe Woody on Q2 2021 Results - Earnings Call Transcript | N/A | |
| 2021-08-03 07:51 EST | News | Avanos Medical EPS misses by $0.02, beats on revenue | N/A | |
| 2021-08-02 13:09 EST | News | Avanos Medical Q2 2021 Earnings Preview | N/A | |
| 2021-07-20 20:36 EST | News | Avanos Medical (AVNS) Presents At Raymond James Human Health Innovation Conference 2021 - Slideshow | N/A | |
| 2021-07-20 20:19 EST | News | Avanos Medical names Moji James as senior vice president & general counsel | N/A | |
| 2021-05-07 04:17 EST | News | Avanos Medical Q1 2021 Earnings Preview | N/A | |
| 2021-02-22 11:09 EST | Analyst Rating | The Analyst Target Price has increased from $50.8 to $52. | Buy | |
| 2021-02-20 07:10 EST | Financials | Company financials have been released. | Neutral | |
| 2021-02-19 11:08 EST | Earnings Estimate | An EPS average of $1.52 is estimated for the 2022 year. | Buy | |
| 2021-02-19 11:08 EST | Earnings Estimate | An EPS average of $0.25 is estimated for the quarter ending on June 30, 2021. | Sell | |
| 2021-02-19 11:08 EST | Analyst Rating | The Analyst Target Price has increased from $47 to $50.8. | Buy | |
| 2021-02-19 06:11 EST | News | Avanos Medical, Inc. 2020 Q4 - Results - Earnings Call Presentation | N/A | |
| 2021-02-19 06:11 EST | News | Avanos Medical, Inc. (AVNS) CEO Joe Woody on Q4 2020 Results - Earnings Call Transcript | N/A | |
| 2021-02-18 11:14 EST | News | Avanos Medical EPS beats by $0.06, beats on revenue | N/A | |
| 2021-02-17 17:38 EST | News | Avanos Medical Q4 2020 Earnings Preview | N/A | |
| 2021-01-23 02:51 EST | News | Avanos Medical (AVNS) Presents At 39th Annual J.P. Morgan Healthcare Conference - Slideshow | N/A | |
| 2021-01-11 07:11 EST | Analyst Rating | The Analyst Target Price has increased from $45.4 to $47. | Neutral | |
| 2021-01-02 15:10 EST | Financials | Company financials have been released. | Neutral | |
| 2020-12-16 11:11 EST | Analyst Rating | The Analyst Target Price has increased from $43.6 to $45.4. | Neutral | |
| 2020-12-13 03:16 EST | Financials | Company financials have been released. | Neutral | |
About Avanos Medical, Inc (AVNS):
Avanos Medical, Inc. operates as a medical technology company that focuses on delivering medical device solutions to improve patients' quality of life in North America, Europe, the Middle East, Africa, the Asia Pacific, and Latin America. It offers a portfolio of chronic care products that include digestive health products, such as Mic-Key enteral feeding tubes, Corpak patient feeding solutions, and NeoMed neonatal and pediatric feeding solutions; and respiratory health products, such as closed airway suction systems and other airway management devices under the Ballard, Microcuff, and Endoclear brands. The company also provides a portfolio of non-opioid pain solutions, including acute pain products, such as On-Q and ambIT surgical pain pumps and Game Ready cold and compression therapy systems; and interventional pain solutions, which offers minimally invasive pain relieving therapies, such as Coolief pain relief therapy. It markets its products directly to hospitals and other healthcare providers, healthcare facilities, and other end-user customers, as well as through third-party wholesale distributors. The company was formerly known as Halyard Health, Inc. and changed its name to Avanos Medical, Inc. in June 2018. Avanos Medical, Inc. was incorporated in 2014 and is headquartered in Alpharetta, Georgia.
General
- Name Avanos Medical, Inc
- Symbol AVNS
- Type Common Stock
- Exchange NYSE
- Currency USD
- Country USA
- SectorHealthcare
- IndustryMedical Devices
- Full Time Employees 5,380
- Fiscal Year EndDecember
- IPO Date2014-10-21
- Gic SectorHealth Care
- Gic GroupHealth Care Equipment & Services
- Gic IndustryHealth Care Equipment & Supplies
- Gic SubIndustryHealth Care Supplies
- Web URLhttp://avanos.com
View More
Valuation
- Trailing PE 159.35
- Price/Sales (Trailing 12 Mt.) 3.21
- Price/Book (Most Recent Quarter) 1.83
- Enterprise Value Revenue 3.41
- Enterprise Value EBITDA 62.32
View More
Financials
- Most Recent Quarter 2020-12-31
- Current Year EPS Estimate $1.19
- Next Year EPS Estimate $1.60
- Next Quarter EPS Estimate $0.19
- Profit Margin -4%
- Operating Margin 1%
- Return on Equity -2%
- Revenue 714.8 million
- Earnings Per Share $0.29
- Revenue Per Share $14.95
- Gross Profit 390.6 million
- Quarterly Earnings Growth -2.5%
View More
Highlights
- Market Capitalization 2.23 billion
- EBITDA 48.8 million
- PE Ratio 144.53
- Analyst Target Price $52
- Book Value Per Share $26.35
View More
Share Statistics
- Shares Outstanding 47.97 million
- Shares Float 47.62 million
- % Held by Insiders 175%
- % Held by Institutions 97.05%
- Shares Short 1.63 million
- Shares Short Prior Month 1.61 million
- Short Ratio 6.7
- Short % of Float 4%
- Short % of Shares Outstanding 3%
View More
Technicals
- Beta 1.01
- 52 Week High $53.61
- 52 Week Low $19.46
- 50 Day Moving Average 47.3
- 200 Day Moving Average 42.36
View More
Dividends
- Dividend Date N/A
- ExDividend Date N/A
- Dividend Yield 0%
View More
Avanos Medical, Inc (AVNS) Dividend Calendar:
| Ex-Dividend Date | Payment Date | Record Date | Declared Date | Amount |
|---|
Avanos Medical, Inc (AVNS) Earnings History:
Companies typically report earnings on both a quarterly and annual basis. Earnings reported that deviate from analysts' expectations can have a large impact on a stock's price.
| Quarter Date | Report Date | Actual Revenue | Reported EPS | EPS Estimate | Deviation from Estimate |
|---|---|---|---|---|---|
| 2020-12-31 | 2021-02-18 | $185 million | $0.28 | $0.22 | 28.44% |
| 2020-09-30 | 2020-11-03 | $185.7 million | $0.21 | $0.10 | 110% |
| 2020-06-30 | 2020-08-04 | $N/A | $0.13 | -$0.10 | 230% |
| 2020-03-31 | 2020-05-06 | $180.4 million | $0.16 | $0.16 | 1.59% |
| 2019-12-31 | 2020-02-25 | $189.8 million | $0.34 | $0.32 | 7.49% |
| 2019-09-30 | 2019-11-05 | $171.4 million | $0.30 | $0.31 | -4% |
| 2019-06-30 | 2019-08-06 | $172.2 million | $0.28 | $0.25 | 10.89% |
| 2019-03-31 | 2019-05-07 | $164.2 million | $0.15 | $0.13 | 13.21% |
| 2018-12-31 | 2019-02-26 | $169.9 million | $0.33 | $0.24 | 40.01% |
| 2018-09-30 | 2018-11-06 | $165.1 million | $0.37 | $0.28 | 32.95% |
| 2018-06-30 | 2018-08-07 | $160.9 million | $0.20 | $0.07 | 207.69% |
| 2018-03-31 | 2018-05-02 | $156.4 million | $0.76 | $0.16 | 390.32% |
| 2017-12-31 | 2018-02-27 | $-584600000 | $0.73 | $0.50 | 47.47% |
| 2017-09-30 | 2017-11-01 | $401.4 million | $0.60 | $0.46 | 31.46% |
| 2017-06-30 | 2017-08-02 | $399.2 million | $0.51 | $0.37 | 37.65% |
| 2017-03-31 | 2017-05-02 | $395.6 million | $0.48 | $0.42 | 13.99% |
| 2016-12-31 | 2017-02-27 | $410 million | $0.50 | $0.44 | 13.46% |
| 2016-09-30 | 2016-11-02 | $397.5 million | $0.48 | $0.39 | 23.05% |
| 2016-06-30 | 2016-08-03 | $400 million | $0.45 | $0.36 | 25.87% |
| 2016-03-31 | 2016-05-04 | $384.8 million | $0.53 | $0.34 | 54.97% |
| 2015-12-31 | 2016-02-29 | $401.4 million | $0.57 | $0.50 | 15.04% |
| 2015-09-30 | 2015-11-03 | $389.5 million | $0.52 | $0.47 | 10.64% |
| 2015-06-30 | 2015-08-04 | $389.3 million | $0.52 | $0.53 | -1.89% |
| 2015-03-31 | 2015-05-04 | $394.2 million | $0.51 | $0.62 | -17.74% |
| 2014-12-31 | 2015-03-04 | $439.4 million | $1.59 | $0.77 | 106.49% |
| 2014-09-30 | 2014-10-21 | $408.5 million | -$0.16 |
Avanos Medical, Inc (AVNS) Company Financial Statements:
Financial statements are reports prepared by a company's management to present their financial performance and position at a point in time. A general-purpose set of financial statements usually includes a balance sheet, income statements, and statement of cash flows.
Income Statement:
| Date |
|---|
| Research Development |
| Income Before Tax |
| Selling General Administrative |
| Gross Profit |
| Ebit |
| Operating Income |
| Income Tax Expense |
| Total Revenue |
| Cost of Revenue |
| Total Other Income Expense Net |
| Net Income From Continuing Operations |
| Net Income Applicable to Common Shares |
Cash Flow:
| Date |
|---|
| Investments |
| Change to Liabilities |
| Total Cash Flow from Investing Activities |
| Net Borrowings |
| Total Cash Flow from Financial Activities |
| Change to Operating Activities |
| Change in Cash |
| Total Cash from Operating Activities |
| Depreciation |
| Other Cash Flow from Investing Activities |
| Change to Inventory |
| Change to Account Receivables |
| Other Cash Flow from Financing Activities |
| Change to Net Income |
| Capital Expenditures |
Balance Sheet:
| Date |
|---|
| Total Liabailities |
| Total Stockholder Equity |
| Other Current Liabilities |
| Total Assets |
| Common Stock |
| Other Current Assets |
| Retained Earnings |
| Other Liabilities |
| Other Assets |
| Cash |
| Total Current Liabilities |
| Other Stockholder Equity |
| Property, Plant & Equipment |
| Total Current Assets |
| Long Term Investments |
| Net Tangible Assets |
| Short Term Investments |
| Long Term Debt |
| Inventory |
| Accounts Payable |
Avanos Medical, Inc (AVNS) Chart:
Avanos Medical, Inc (AVNS) News:
Below you will find a list of latest news for Avanos Medical, Inc (AVNS) from major news sources. You can filter the results to only show news from a specific source.
No recent news available
Avanos Medical, Inc (AVNS) Options:
A stock option is a contract between two parties in which the stock option buyer (holder) purchases the right (but not the obligation) to buy/sell 100 shares of an underlying stock at a predetermined price from/to the option seller (writer) within a fixed period of time.
| Expiration Date | Strike | Last Price | Type | Volume | Open Interest | Implied Volatility | In The Money | Change | Change Percent |
|---|---|---|---|---|---|---|---|---|---|
| 2025-01-17 | 2.5 | 0 | CALL | 0 | 0 | 269.38 | TRUE | 0 | 0 |
| 2025-01-17 | 5 | 0 | CALL | 0 | 0 | 200.73 | TRUE | 0 | 0 |
| 2025-01-17 | 7.5 | 0 | CALL | 0 | 0 | 146.9 | TRUE | 0 | 0 |
| 2025-01-17 | 10 | 0 | CALL | 0 | 0 | 145.91 | TRUE | 0 | 0 |
| 2025-01-17 | 12.5 | 0 | CALL | 0 | 0 | 119.97 | TRUE | 0 | 0 |
| 2025-01-17 | 15 | 0 | CALL | 0 | 0 | 94.1 | TRUE | 0 | 0 |
| 2025-01-17 | 17.5 | 0 | CALL | 0 | 0 | 74.95 | TRUE | 0 | 0 |
| 2025-01-17 | 20 | 0 | CALL | 0 | 0 | 57.95 | TRUE | 0 | 0 |
| 2025-01-17 | 22.5 | 3.83 | CALL | 0 | 15 | 38.48 | TRUE | 0 | 0 |
| 2025-01-17 | 25 | 1.25 | CALL | 0 | 31 | 0 | FALSE | 0 | 0 |
| 2025-01-17 | 30 | 0 | CALL | 0 | 0 | 0 | FALSE | 0 | 0 |
| 2025-01-17 | 35 | 0 | CALL | 0 | 0 | 0 | FALSE | 0 | 0 |
| 2025-01-17 | 2.5 | 0 | PUT | 0 | 0 | 0 | FALSE | 0 | 0 |
| 2025-01-17 | 5 | 0 | PUT | 0 | 0 | 0 | FALSE | 0 | 0 |
| 2025-01-17 | 7.5 | 0 | PUT | 0 | 0 | 0 | FALSE | 0 | 0 |
| 2025-01-17 | 10 | 0 | PUT | 0 | 0 | 0 | FALSE | 0 | 0 |
| 2025-01-17 | 12.5 | 0 | PUT | 0 | 0 | 0 | FALSE | 0 | 0 |
| 2025-01-17 | 15 | 0 | PUT | 0 | 0 | 0 | FALSE | 0 | 0 |
| 2025-01-17 | 17.5 | 0.9 | PUT | 0 | 10 | 0 | FALSE | 0 | 0 |
| 2025-01-17 | 20 | 1.1 | PUT | 0 | 1 | 0 | FALSE | 0 | 0 |
| 2025-01-17 | 22.5 | 2.1 | PUT | 0 | 5 | 41.86 | FALSE | 0 | 0 |
| 2025-01-17 | 25 | 5.6 | PUT | 0 | 11 | 45.06 | TRUE | 0 | 0 |
| 2025-01-17 | 30 | 0 | PUT | 0 | 0 | 32.22 | TRUE | 0 | 0 |
| 2025-01-17 | 35 | 0 | PUT | 0 | 0 | 70.21 | TRUE | 0 | 0 |
| 2025-04-17 | 12.5 | 0 | CALL | 0 | 0 | 83.56 | TRUE | 0 | 0 |
| 2025-04-17 | 15 | 0 | CALL | 0 | 0 | 69.29 | TRUE | 0 | 0 |
| 2025-04-17 | 17.5 | 0 | CALL | 0 | 0 | 53.68 | TRUE | 0 | 0 |
| 2025-04-17 | 20 | 0 | CALL | 0 | 0 | 44.19 | TRUE | 0 | 0 |
| 2025-04-17 | 22.5 | 0 | CALL | 0 | 0 | 37.45 | TRUE | 0 | 0 |
| 2025-04-17 | 25 | 2 | CALL | 0 | 1 | 0 | FALSE | 0 | 0 |
| 2025-04-17 | 30 | 0 | CALL | 0 | 0 | 0 | FALSE | 0 | 0 |
| 2025-04-17 | 12.5 | 0 | PUT | 0 | 0 | 0 | FALSE | 0 | 0 |
| 2025-04-17 | 15 | 0 | PUT | 0 | 0 | 0 | FALSE | 0 | 0 |
| 2025-04-17 | 17.5 | 0 | PUT | 0 | 0 | 0 | FALSE | 0 | 0 |
| 2025-04-17 | 20 | 0 | PUT | 0 | 0 | 39.25 | FALSE | 0 | 0 |
| 2025-04-17 | 22.5 | 0 | PUT | 0 | 0 | 0 | FALSE | 0 | 0 |
| 2025-04-17 | 25 | 0 | PUT | 0 | 0 | 27.16 | TRUE | 0 | 0 |
| 2025-04-17 | 30 | 0 | PUT | 0 | 0 | 54.31 | TRUE | 0 | 0 |
Latest AVNS Trades:
| Date | Shares | Price |
|---|---|---|
| Jun 13, 2022 7:59 PM EST | 18 | $25.61 |
| Jun 13, 2022 7:59 PM EST | 4 | $25.64 |
| Jun 13, 2022 7:59 PM EST | 5 | $25.64 |
| Jun 13, 2022 7:59 PM EST | 5 | $25.64 |
| Jun 13, 2022 7:59 PM EST | 24 | $25.63 |
Avanos Medical, Inc (AVNS) SEC Filings:
An SEC filing is a financial statement or other formal document submitted to the U.S. Securities and Exchange Commission (SEC). Public companies, certain insiders, and broker-dealers are required to make regular SEC filings.
| Date | Form Type | Form Name | Link |
|---|---|---|---|
| 2020-06-30 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1606498/000160649820000040/0001606498-20-000040-index.htm |
| 2018-12-07 | UPLOAD | SEC-generated letter | https://www.sec.gov/Archives/edgar/data/1606498/000000000018037492/0000000000-18-037492-index.htm |
| 2019-02-19 | UPLOAD | SEC-generated letter | https://www.sec.gov/Archives/edgar/data/1606498/000000000019002662/0000000000-19-002662-index.htm |
| 2019-11-26 | UPLOAD | SEC-generated letter | https://www.sec.gov/Archives/edgar/data/1606498/000000000019015890/0000000000-19-015890-index.htm |
| 2019-12-20 | UPLOAD | SEC-generated letter | https://www.sec.gov/Archives/edgar/data/1606498/000000000019016679/0000000000-19-016679-index.htm |
| 2020-01-23 | UPLOAD | SEC-generated letter | https://www.sec.gov/Archives/edgar/data/1606498/000000000020000627/0000000000-20-000627-index.htm |
| 2019-02-14 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1606498/000008025519002677/0000080255-19-002677-index.htm |
| 2020-02-14 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1606498/000008025520001273/0000080255-20-001273-index.htm |
| 2019-01-24 | SC 13G | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1606498/000021545719000922/0000215457-19-000922-index.htm |
| 2020-02-04 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1606498/000083423720001562/0000834237-20-001562-index.htm |
| 2019-02-11 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1606498/000093247119004665/0000932471-19-004665-index.htm |
| 2020-02-12 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1606498/000110465920017726/0001104659-20-017726-index.htm |
| 2020-03-06 | PRE 14A | Other preliminary proxy statements | https://www.sec.gov/Archives/edgar/data/1606498/000110465920030180/0001104659-20-030180-index.htm |
| 2020-03-16 | DEF 14A | Other definitive proxy statements | https://www.sec.gov/Archives/edgar/data/1606498/000110465920033966/0001104659-20-033966-index.htm |
| 2019-02-08 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1606498/000125889719001009/0001258897-19-001009-index.htm |
| 2020-02-12 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1606498/000125889720000804/0001258897-20-000804-index.htm |
| 2020-02-13 | SC 13G | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1606498/000131547820000014/0001315478-20-000014-index.htm |
| 2019-03-15 | DEF 14A | Other definitive proxy statements | https://www.sec.gov/Archives/edgar/data/1606498/000155278119000099/0001552781-19-000099-index.htm |
| 2019-03-15 | DEFA14A | Additional definitive proxy soliciting materials and Rule 14(a)(12) material | https://www.sec.gov/Archives/edgar/data/1606498/000155278119000100/0001552781-19-000100-index.htm |
| 2019-04-17 | DEFA14A | Additional definitive proxy soliciting materials and Rule 14(a)(12) material | https://www.sec.gov/Archives/edgar/data/1606498/000155278119000172/0001552781-19-000172-index.htm |
| 2018-11-06 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1606498/000156459018027080/0001564590-18-027080-index.htm |
| 2018-11-06 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1606498/000156459018027419/0001564590-18-027419-index.htm |
| 2019-06-28 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1606498/000160603619000001/0001606036-19-000001-index.htm |
| 2018-05-04 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1606498/000160649818000042/0001606498-18-000042-index.htm |
| 2018-05-04 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1606498/000160649818000043/0001606498-18-000043-index.htm |
| 2018-05-04 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1606498/000160649818000044/0001606498-18-000044-index.htm |
| 2018-05-04 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1606498/000160649818000045/0001606498-18-000045-index.htm |
| 2018-05-04 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1606498/000160649818000046/0001606498-18-000046-index.htm |
| 2018-05-04 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1606498/000160649818000047/0001606498-18-000047-index.htm |
| 2018-05-04 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1606498/000160649818000048/0001606498-18-000048-index.htm |
| 2018-05-29 | SD | https://www.sec.gov/Archives/edgar/data/1606498/000160649818000050/0001606498-18-000050-index.htm | |
| 2018-06-01 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1606498/000160649818000053/0001606498-18-000053-index.htm |
| 2018-06-04 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1606498/000160649818000055/0001606498-18-000055-index.htm |
| 2018-06-21 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1606498/000160649818000059/0001606498-18-000059-index.htm |
| 2018-06-28 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1606498/000160649818000061/0001606498-18-000061-index.htm |
| 2018-08-07 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1606498/000160649818000066/0001606498-18-000066-index.htm |
| 2018-08-07 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1606498/000160649818000068/0001606498-18-000068-index.htm |
| 2018-08-23 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1606498/000160649818000070/0001606498-18-000070-index.htm |
| 2018-10-30 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1606498/000160649818000072/0001606498-18-000072-index.htm |
| 2018-11-20 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1606498/000160649818000074/0001606498-18-000074-index.htm |
| 2018-11-28 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1606498/000160649818000076/0001606498-18-000076-index.htm |
| 2018-11-29 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1606498/000160649818000077/0001606498-18-000077-index.htm |
| 2018-12-07 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1606498/000160649818000078/0001606498-18-000078-index.htm |
| 2018-12-17 | 10-Q/A | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1606498/000160649818000081/0001606498-18-000081-index.htm |
| 2019-01-04 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1606498/000160649819000001/0001606498-19-000001-index.htm |
| 2019-01-04 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1606498/000160649819000002/0001606498-19-000002-index.htm |
| 2019-01-04 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1606498/000160649819000003/0001606498-19-000003-index.htm |
| 2019-01-04 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1606498/000160649819000004/0001606498-19-000004-index.htm |
| 2019-01-04 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1606498/000160649819000005/0001606498-19-000005-index.htm |
| 2019-01-04 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1606498/000160649819000006/0001606498-19-000006-index.htm |
| 2019-01-04 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1606498/000160649819000007/0001606498-19-000007-index.htm |
| 2019-01-04 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1606498/000160649819000008/0001606498-19-000008-index.htm |
| 2019-01-29 | CORRESP | Correspondence | https://www.sec.gov/Archives/edgar/data/1606498/000160649819000010/0001606498-19-000010-index.htm |
| 2019-02-05 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1606498/000160649819000011/0001606498-19-000011-index.htm |
| 2019-02-26 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1606498/000160649819000015/0001606498-19-000015-index.htm |
| 2019-02-26 | 10-K | Annual report [Section 13 and 15(d), not S-K Item 405] | https://www.sec.gov/Archives/edgar/data/1606498/000160649819000018/0001606498-19-000018-index.htm |
| 2019-03-05 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1606498/000160649819000019/0001606498-19-000019-index.htm |
| 2019-03-05 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1606498/000160649819000020/0001606498-19-000020-index.htm |
| 2019-03-13 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1606498/000160649819000021/0001606498-19-000021-index.htm |
| 2019-04-18 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1606498/000160649819000023/0001606498-19-000023-index.htm |
| 2019-05-01 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1606498/000160649819000025/0001606498-19-000025-index.htm |
| 2019-05-06 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1606498/000160649819000027/0001606498-19-000027-index.htm |
| 2019-05-06 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1606498/000160649819000028/0001606498-19-000028-index.htm |
| 2019-05-07 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1606498/000160649819000030/0001606498-19-000030-index.htm |
| 2019-05-07 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1606498/000160649819000032/0001606498-19-000032-index.htm |
| 2019-05-07 | 4/A | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1606498/000160649819000033/0001606498-19-000033-index.htm |
| 2019-05-07 | 4/A | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1606498/000160649819000034/0001606498-19-000034-index.htm |
| 2019-05-07 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1606498/000160649819000035/0001606498-19-000035-index.htm |
| 2019-05-08 | 4/A | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1606498/000160649819000036/0001606498-19-000036-index.htm |
| 2019-05-08 | 4/A | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1606498/000160649819000037/0001606498-19-000037-index.htm |
| 2019-05-08 | 4/A | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1606498/000160649819000038/0001606498-19-000038-index.htm |
| 2019-05-08 | 4/A | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1606498/000160649819000039/0001606498-19-000039-index.htm |
| 2019-05-10 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1606498/000160649819000040/0001606498-19-000040-index.htm |
| 2019-05-10 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1606498/000160649819000041/0001606498-19-000041-index.htm |
| 2019-05-10 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1606498/000160649819000042/0001606498-19-000042-index.htm |
| 2019-05-10 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1606498/000160649819000043/0001606498-19-000043-index.htm |
| 2019-05-10 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1606498/000160649819000044/0001606498-19-000044-index.htm |
| 2019-05-10 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1606498/000160649819000045/0001606498-19-000045-index.htm |
| 2019-05-10 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1606498/000160649819000046/0001606498-19-000046-index.htm |
| 2019-05-22 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1606498/000160649819000047/0001606498-19-000047-index.htm |
| 2019-05-30 | SD | https://www.sec.gov/Archives/edgar/data/1606498/000160649819000049/0001606498-19-000049-index.htm | |
| 2019-06-03 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1606498/000160649819000050/0001606498-19-000050-index.htm |
| 2019-06-05 | 3/A | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1606498/000160649819000051/0001606498-19-000051-index.htm |
| 2019-06-18 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1606498/000160649819000054/0001606498-19-000054-index.htm |
| 2019-06-25 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1606498/000160649819000055/0001606498-19-000055-index.htm |
| 2019-08-06 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1606498/000160649819000057/0001606498-19-000057-index.htm |
| 2019-08-06 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1606498/000160649819000062/0001606498-19-000062-index.htm |
| 2019-08-07 | S-8 | Securities to be offered to employees in employee benefit plans | https://www.sec.gov/Archives/edgar/data/1606498/000160649819000064/0001606498-19-000064-index.htm |
| 2019-08-21 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1606498/000160649819000066/0001606498-19-000066-index.htm |
| 2019-11-05 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1606498/000160649819000070/0001606498-19-000070-index.htm |
| 2019-11-05 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1606498/000160649819000072/0001606498-19-000072-index.htm |
| 2019-12-18 | CORRESP | Correspondence | https://www.sec.gov/Archives/edgar/data/1606498/000160649819000074/0001606498-19-000074-index.htm |
| 2019-12-30 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1606498/000160649819000077/0001606498-19-000077-index.htm |
| 2020-01-06 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1606498/000160649820000001/0001606498-20-000001-index.htm |
| 2020-01-08 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1606498/000160649820000002/0001606498-20-000002-index.htm |
| 2020-01-08 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1606498/000160649820000003/0001606498-20-000003-index.htm |
| 2020-01-08 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1606498/000160649820000004/0001606498-20-000004-index.htm |
| 2020-01-08 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1606498/000160649820000005/0001606498-20-000005-index.htm |
| 2020-01-08 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1606498/000160649820000006/0001606498-20-000006-index.htm |
| 2020-01-08 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1606498/000160649820000007/0001606498-20-000007-index.htm |
| 2020-01-08 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1606498/000160649820000008/0001606498-20-000008-index.htm |
| 2020-01-08 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1606498/000160649820000009/0001606498-20-000009-index.htm |
| 2020-01-08 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1606498/000160649820000010/0001606498-20-000010-index.htm |
| 2020-01-17 | CORRESP | Correspondence | https://www.sec.gov/Archives/edgar/data/1606498/000160649820000012/0001606498-20-000012-index.htm |
| 2020-02-25 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1606498/000160649820000016/0001606498-20-000016-index.htm |
| 2020-02-25 | 10-K | Annual report [Section 13 and 15(d), not S-K Item 405] | https://www.sec.gov/Archives/edgar/data/1606498/000160649820000018/0001606498-20-000018-index.htm |
| 2020-04-16 | DEFA14A | Additional definitive proxy soliciting materials and Rule 14(a)(12) material | https://www.sec.gov/Archives/edgar/data/1606498/000160649820000022/0001606498-20-000022-index.htm |
| 2020-05-06 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1606498/000160649820000027/0001606498-20-000027-index.htm |
| 2020-05-06 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1606498/000160649820000028/0001606498-20-000028-index.htm |
| 2020-05-06 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1606498/000160649820000029/0001606498-20-000029-index.htm |
| 2020-05-06 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1606498/000160649820000030/0001606498-20-000030-index.htm |
| 2020-05-11 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1606498/000160649820000031/0001606498-20-000031-index.htm |
| 2020-05-11 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1606498/000160649820000032/0001606498-20-000032-index.htm |
| 2020-05-11 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1606498/000160649820000033/0001606498-20-000033-index.htm |
| 2020-05-11 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1606498/000160649820000034/0001606498-20-000034-index.htm |
| 2020-05-11 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1606498/000160649820000035/0001606498-20-000035-index.htm |
| 2020-05-11 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1606498/000160649820000036/0001606498-20-000036-index.htm |
| 2020-05-11 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1606498/000160649820000037/0001606498-20-000037-index.htm |
| 2020-05-27 | SD | https://www.sec.gov/Archives/edgar/data/1606498/000160649820000039/0001606498-20-000039-index.htm | |
| 2020-06-30 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1606498/000160649820000040/0001606498-20-000040-index.htm |
| 2020-08-04 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1606498/000160649820000045/0001606498-20-000045-index.htm |
| 2020-08-04 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1606498/000160649820000047/0001606498-20-000047-index.htm |
| 2020-09-01 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1606498/000160649820000052/0001606498-20-000052-index.htm |
| 2020-09-02 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1606498/000160649820000053/0001606498-20-000053-index.htm |
| 2020-09-02 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1606498/000160649820000054/0001606498-20-000054-index.htm |
| 2020-10-26 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1606498/000160649820000057/0001606498-20-000057-index.htm |
| 2020-11-03 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1606498/000160649820000061/0001606498-20-000061-index.htm |
| 2020-11-03 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1606498/000160649820000063/0001606498-20-000063-index.htm |
Avanos Medical, Inc (AVNS) Insider Transactions:
Here you will find a list of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Avanos Medical, Inc (AVNS). Company insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise.Insider Ownership: 175%Institutional Ownership: 9705%
| Transaction Date | Insider Name | Insider Title | Type | Shares Number | Shares Price | Total Transaction | Shares Held After Transaction | Link |
|---|---|---|---|---|---|---|---|---|
| 2018-05-03 | Renato Negro | Vice President - Controller | Buy | 624.00 | 10,005.00 | https://www.sec.gov/Archives/edgar/data/1606498/000160649818000046/0001606498-18-000046-index.htm | ||
| 2020-05-07 | Arjun Ranjan Sarker | Senior VP, International | Buy | 8,253.00 | 30.67 | 253,119.51 | 13,072.00 | https://www.sec.gov/Archives/edgar/data/1606498/000160649820000037/0001606498-20-000037-index.htm |
| 2020-01-02 | Michael Greiner | SVP - Chief Financial Officer | Buy | 14,702.00 | 34.01 | 500,015.02 | 14,702.00 | https://www.sec.gov/Archives/edgar/data/1606498/000160649820000002/0001606498-20-000002-index.htm |
| 2018-05-03 | Julie Ann Shimer | Director | Buy | 384.00 | 15,304.00 | https://www.sec.gov/Archives/edgar/data/1606498/000160649818000042/0001606498-18-000042-index.htm | ||
| 2018-12-06 | Renato Negro | Vice President - Controller | Buy | 5,447.00 | 45.90 | 250,017.30 | 15,452.00 | https://www.sec.gov/Archives/edgar/data/1606498/000160649818000078/0001606498-18-000078-index.htm |
| 2020-05-07 | Joseph Fralin Woody | Chief Executive Officer | Buy | 129,850.00 | 30.67 | 3,982,499.50 | 155,595.00 | https://www.sec.gov/Archives/edgar/data/1606498/000160649820000031/0001606498-20-000031-index.htm |
| 2019-05-08 | Renato Negro | Vice President - Controller | Buy | 717.00 | 16,983.00 | https://www.sec.gov/Archives/edgar/data/1606498/000160649819000040/0001606498-19-000040-index.htm | ||
| 2019-05-05 | Renato Negro | Vice President - Controller | Buy | 1,669.00 | 45.81 | 76,456.89 | 17,121.00 | https://www.sec.gov/Archives/edgar/data/1606498/000160649819000035/0001606498-19-000035-index.htm |
| 2019-01-02 | Maria Sainz | Director | Buy | 4,248.00 | 18,744.00 | https://www.sec.gov/Archives/edgar/data/1606498/000160649819000008/0001606498-19-000008-index.htm | ||
| 2019-01-02 | GARY BLACKFORD | Director | Buy | 4,248.00 | 19,552.00 | https://www.sec.gov/Archives/edgar/data/1606498/000160649819000004/0001606498-19-000004-index.htm | ||
| 2019-01-02 | Julie Ann Shimer | Director | Buy | 4,248.00 | 19,552.00 | https://www.sec.gov/Archives/edgar/data/1606498/000160649819000002/0001606498-19-000002-index.htm | ||
| 2019-01-02 | RONALD W DOLLENS | Director | Buy | 4,248.00 | 19,552.00 | https://www.sec.gov/Archives/edgar/data/1606498/000160649819000005/0001606498-19-000005-index.htm | ||
| 2019-01-02 | HEIDI FIELDS | Director | Buy | 4,248.00 | 19,557.00 | https://www.sec.gov/Archives/edgar/data/1606498/000160649819000001/0001606498-19-000001-index.htm | ||
| 2019-01-02 | JOHN P BYRNES | Director | Buy | 4,248.00 | 19,580.00 | https://www.sec.gov/Archives/edgar/data/1606498/000160649819000006/0001606498-19-000006-index.htm | ||
| 2019-01-02 | PATRICK J OLEARY | Director | Buy | 4,248.00 | 19,602.00 | https://www.sec.gov/Archives/edgar/data/1606498/000160649819000007/0001606498-19-000007-index.htm | ||
| 2019-05-20 | Renato Negro | Vice President - Controller | Buy | 2,940.00 | 42.52 | 125,008.80 | 19,923.00 | https://www.sec.gov/Archives/edgar/data/1606498/000160649819000047/0001606498-19-000047-index.htm |
| 2020-01-02 | RONALD W DOLLENS | Director | Buy | 1,764.00 | 21,316.00 | https://www.sec.gov/Archives/edgar/data/1606498/000160649820000010/0001606498-20-000010-index.htm | ||
| 2019-01-02 | WILLIAM A HAWKINS | Director | Buy | 4,248.00 | 21,899.00 | https://www.sec.gov/Archives/edgar/data/1606498/000160649819000003/0001606498-19-000003-index.htm | ||
| 2018-11-27 | Steven E Voskuil | SVP, Chief Financial Officer | Buy | 2,000.00 | 43.74 | 87,470.00 | 22,238.00 | https://www.sec.gov/Archives/edgar/data/1606498/000160649818000076/0001606498-18-000076-index.htm |
| 2020-05-07 | Renato Negro | Vice President - Controller | Buy | 3,668.00 | 30.67 | 112,497.56 | 22,690.00 | https://www.sec.gov/Archives/edgar/data/1606498/000160649820000034/0001606498-20-000034-index.htm |
| 2020-01-02 | Maria Sainz | Director | Buy | 5,293.00 | 24,037.00 | https://www.sec.gov/Archives/edgar/data/1606498/000160649820000006/0001606498-20-000006-index.htm | ||
| 2020-01-02 | GARY BLACKFORD | Director | Buy | 5,293.00 | 24,845.00 | https://www.sec.gov/Archives/edgar/data/1606498/000160649820000003/0001606498-20-000003-index.htm | ||
| 2020-01-02 | Julie Ann Shimer | Director | Buy | 5,293.00 | 24,845.00 | https://www.sec.gov/Archives/edgar/data/1606498/000160649820000005/0001606498-20-000005-index.htm | ||
| 2020-01-02 | HEIDI FIELDS | Director | Buy | 5,293.00 | 24,850.00 | https://www.sec.gov/Archives/edgar/data/1606498/000160649820000008/0001606498-20-000008-index.htm | ||
| 2020-01-02 | JOHN P BYRNES | Director | Buy | 5,293.00 | 24,873.00 | https://www.sec.gov/Archives/edgar/data/1606498/000160649820000009/0001606498-20-000009-index.htm | ||
| 2020-01-02 | PATRICK J OLEARY | Director | Buy | 5,293.00 | 24,895.00 | https://www.sec.gov/Archives/edgar/data/1606498/000160649820000007/0001606498-20-000007-index.htm | ||
| 2018-11-28 | Joseph Fralin Woody | Chief Executive Officer | Buy | 3,500.00 | 43.35 | 151,725.00 | 25,056.00 | https://www.sec.gov/Archives/edgar/data/1606498/000160649818000077/0001606498-18-000077-index.htm |
| 2020-05-07 | Renato Negro | Vice President - Controller | Buy | 2,445.00 | 30.67 | 74,988.15 | 25,135.00 | https://www.sec.gov/Archives/edgar/data/1606498/000160649820000034/0001606498-20-000034-index.htm |
| 2020-01-02 | WILLIAM A HAWKINS | Director | Buy | 5,293.00 | 27,192.00 | https://www.sec.gov/Archives/edgar/data/1606498/000160649820000004/0001606498-20-000004-index.htm | ||
| 2019-05-30 | Joseph Fralin Woody | Chief Executive Officer | Buy | 3,500.00 | 39.95 | 139,825.00 | 28,556.00 | https://www.sec.gov/Archives/edgar/data/1606498/000160649819000050/0001606498-19-000050-index.htm |
| 2020-05-08 | GARY BLACKFORD | Director | Buy | 5,000.00 | 29.00 | 145,000.00 | 29,845.00 | https://www.sec.gov/Archives/edgar/data/1606498/000160649820000032/0001606498-20-000032-index.htm |
| 2020-05-07 | John W Wesley | SVP, General Counsel | Buy | 16,506.00 | 30.67 | 506,239.02 | 30,135.00 | https://www.sec.gov/Archives/edgar/data/1606498/000160649820000035/0001606498-20-000035-index.htm |
| 2020-05-08 | GARY BLACKFORD | Director | Buy | 5,000.00 | 28.50 | 142,500.00 | 34,845.00 | https://www.sec.gov/Archives/edgar/data/1606498/000160649820000032/0001606498-20-000032-index.htm |
| 2020-05-07 | Michael Greiner | SVP - Chief Financial Officer | Buy | 36,681.00 | 30.67 | 1,125,006.27 | 51,383.00 | https://www.sec.gov/Archives/edgar/data/1606498/000160649820000036/0001606498-20-000036-index.htm |
| 2020-08-31 | William David Haydon | SVP, GM Pain Franchise | Buy | 6,173.00 | 32.40 | 200,005.20 | 6,173.00 | https://www.sec.gov/Archives/edgar/data/1606498/000160649820000054/0001606498-20-000054-index.htm |
| 2018-05-03 | Arjun Ranjan Sarker | Senior VP, International | Buy | 3,189.00 | 7,189.00 | https://www.sec.gov/Archives/edgar/data/1606498/000160649818000043/0001606498-18-000043-index.htm | ||
| 2018-11-19 | John W Wesley | SVP, General Counsel | Buy | 1,000.00 | 47.48 | 47,480.00 | 7,502.00 | https://www.sec.gov/Archives/edgar/data/1606498/000160649818000074/0001606498-18-000074-index.htm |
| 2020-05-07 | David Edward Ball | SVP - Global Supply Chain | Buy | 8,253.00 | 30.67 | 253,119.51 | 8,253.00 | https://www.sec.gov/Archives/edgar/data/1606498/000160649820000033/0001606498-20-000033-index.htm |